Literature DB >> 17507545

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Klaus F Rabe1, Suzanne Hurd, Antonio Anzueto, Peter J Barnes, Sonia A Buist, Peter Calverley, Yoshinosuke Fukuchi, Christine Jenkins, Roberto Rodriguez-Roisin, Chris van Weel, Jan Zielinski.   

Abstract

Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is the fourth leading cause of chronic morbidity and mortality in the United States, and is projected to rank fifth in 2020 in burden of disease worldwide, according to a study published by the World Bank/World Health Organization. Yet, COPD remains relatively unknown or ignored by the public as well as public health and government officials. In 1998, in an effort to bring more attention to COPD, its management, and its prevention, a committed group of scientists encouraged the U.S. National Heart, Lung, and Blood Institute and the World Health Organization to form the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Among the important objectives of GOLD are to increase awareness of COPD and to help the millions of people who suffer from this disease and die prematurely of it or its complications. The first step in the GOLD program was to prepare a consensus report, Global Strategy for the Diagnosis, Management, and Prevention of COPD, published in 2001. The present, newly revised document follows the same format as the original consensus report, but has been updated to reflect the many publications on COPD that have appeared. GOLD national leaders, a network of international experts, have initiated investigations of the causes and prevalence of COPD in their countries, and developed innovative approaches for the dissemination and implementation of COPD management guidelines. We appreciate the enormous amount of work the GOLD national leaders have done on behalf of their patients with COPD. Despite the achievements in the 5 years since the GOLD report was originally published, considerable additional work is ahead of us if we are to control this major public health problem. The GOLD initiative will continue to bring COPD to the attention of governments, public health officials, health care workers, and the general public, but a concerted effort by all involved in health care will be necessary.

Entities:  

Mesh:

Year:  2007        PMID: 17507545     DOI: 10.1164/rccm.200703-456SO

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  2000 in total

Review 1.  Autophagy in cigarette smoke-induced chronic obstructive pulmonary disease.

Authors:  Stefan W Ryter; Seon-Jin Lee; Augustine Mk Choi
Journal:  Expert Rev Respir Med       Date:  2010-10       Impact factor: 3.772

Review 2.  Umeclidinium/vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease.

Authors:  Hannah A Blair; Emma D Deeks
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

3.  Identifying key domains of health-related quality of life for patients with chronic obstructive pulmonary disease: interviews with healthcare professionals.

Authors:  Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen
Journal:  Qual Life Res       Date:  2014-11-16       Impact factor: 4.147

4.  Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis.

Authors:  Hong Xue; Jian Su; Kai Sun; Weiping Xie; Hong Wang
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

5.  Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation.

Authors:  Jung-Wan Yoo; Yoonki Hong; Joon Beom Seo; Eun Jin Chae; Seung Won Ra; Ji-Hyun Lee; Eun Kyung Kim; Seunghee Baek; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Seung Soo Sheen; Jae Seung Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

6.  GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Authors:  MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make
Journal:  Lancet Respir Med       Date:  2012-09-03       Impact factor: 30.700

7.  Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.

Authors:  Sandy S Chang; Shu Chen; Gail J McAvay; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

8.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

Authors:  Emma L Beckett; Richard L Stevens; Andrew G Jarnicki; Richard Y Kim; Irwan Hanish; Nicole G Hansbro; Andrew Deane; Simon Keely; Jay C Horvat; Ming Yang; Brian G Oliver; Nico van Rooijen; Mark D Inman; Roberto Adachi; Roy J Soberman; Sahar Hamadi; Peter A Wark; Paul S Foster; Philip M Hansbro
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

Review 9.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

10.  Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer.

Authors:  Isaac K Sundar; Michael Z Nevid; Alan E Friedman; Irfan Rahman
Journal:  J Proteome Res       Date:  2013-12-13       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.